Intelligent Medical Imaging (IMI) gets clearance for Micro21 applications:
This article was originally published in Clinica
The US FDA has cleared two new tests for Intelligent Medical Imaging's Micro21 system, reticulocyte counting and anti-nuclear antibody analysis. Micro21, a neural network microscopy system is marketed by Coulter.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.